Viemed Healthcare (VMD) director sells 20,000 common shares
Rhea-AI Filing Summary
VIEMED HEALTHCARE, INC. director Timothy Smokoff reported open-market sales of a total of 20,000 Common Shares of VMD on June 24, 2026. The transactions were executed in five separate trades at prices ranging from $11.41 to $11.56 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 20,000 shares ($229,967)
Net Sell
5 txns
Insider
Smokoff Timothy
Role
Director
Sold
20,000 shs ($230K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 1,636 | $11.48 | $19K |
| Sale | Common Shares | 3,364 | $11.50 | $39K |
| Sale | Common Shares | 5,000 | $11.56 | $58K |
| Sale | Common Shares | 5,000 | $11.53 | $58K |
| Sale | Common Shares | 5,000 | $11.41 | $57K |
Holdings After Transaction:
Common Shares — 93,882 shares (Direct)
Footnotes (1)
Key Figures
Total shares sold: 20,000 Common Shares
Lowest sale price: $11.41 per share
Highest sale price: $11.56 per share
+3 more
6 metrics
Total shares sold
20,000 Common Shares
Aggregate open-market sales on June 24, 2026
Lowest sale price
$11.41 per share
One of five open-market sales on June 24, 2026
Highest sale price
$11.56 per share
One of five open-market sales on June 24, 2026
Individual sale size
5,000 Common Shares
Three of the five reported transactions on June 24, 2026
Additional sale sizes
3,364 and 1,636 Common Shares
Two smaller open-market sales on June 24, 2026
Number of sale transactions
5 transactions
Non-derivative open-market sales reported on Form 4
Key Terms
open-market sale, non-derivative, transaction code "S", Common Shares, +1 more
5 terms
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
"transaction_type: "non-derivative" for Common Shares"
transaction code "S" financial
"transaction_code: "S" with description "Sale in open market or private transaction""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Viemed Healthcare (VMD) report for Timothy Smokoff?
Viemed Healthcare reported that director Timothy Smokoff sold 20,000 Common Shares on June 24, 2026. The sales were open-market transactions, disclosed on Form 4, and involved multiple trades at prices between $11.41 and $11.56 per share.
What type of transactions did Timothy Smokoff’s Viemed Healthcare (VMD) Form 4 report?
The Form 4 reports non-derivative open-market sale transactions in Viemed Healthcare Common Shares. Each transaction is coded “S,” indicating sales in the open market or private transaction, rather than option exercises, gifts, or tax-withholding events.
Does Timothy Smokoff’s Viemed Healthcare (VMD) Form 4 show any option exercises or derivative trades?
The Form 4 shows no derivative transactions or option exercises for Timothy Smokoff. All reported activity involves non-derivative Common Shares, with five open-market sales totaling 20,000 shares and no derivative positions listed in the derivative transaction summary.